"We live in absolutely revolutionary times from the standpoint of biomedical research and what we've learned about disease biology over the last decade or two. Third Rock appreciates this unprecedented opportunity to advance the application of game-changing biology to human health and is appropriately taking a much longer-term perspective on exactly how and when such technology is going to pay off."
Steven Paul, M.D.
Venture Partner of Third Rock Ventures and Co-founde of
SAGE Therapeutics
